TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY
2.2 RESEARCH OBJECTIVE
2.3 LIST OF ASSUMPTIONS
3 RESEARCH METHODOLOGY
3.1 OVERVIEW
3.2 DATA MINING
3.3 SECONDARY RESEARCH
3.4 PRIMARY RESEARCH
3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 GROWING PREVALENCE OF EPILEPSY AMONGST THE GERIATRIC POPULATION
4.2.2 INCREASING CASES OF BRAIN INJURIES DUE TO ROAD ACCIDENTS
4.2.3 RISING NEUROLOGICAL DISORDERS
4.3 RESTRAINTS
4.3.1 LACK OF PUBLIC AWARENESS AND AVAILABILITY OF EPILEPSY DEVICES IN DEVELOPING NATIONS
4.4 OPPORTUNITIES
4.4.1 EMERGING MARKETS FOR EPILEPSY DEVICES
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION AND SALES
5.1.4 POST-SALES MONITORING
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF BUYERS
5.2.3 THREAT OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTES
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE EPILEPSY DEVICES MARKET
5.3.1 IMPACT ON DEMAND
5.3.2 IMPACT ON EPILEPSY PATIENTS
5.3.3 IMPACT ON GDP
5.3.4 IMPACT ON SUPPLY CHAIN
5.4 ESTIMATION OF ELIGIBLE PATIENTS AND SURGICAL CASE LOADS/TREATMENT IN EPILEPSY
6 GLOBAL EPILEPESY DEVICES MARKET, BY PRODUCT TYPE
6.1 OVERVIEW
6.2 CONVENTIONAL DEVICES
6.3 WERABLE DEVICES
6.3.1 WATCHES
6.3.2 BRACELETS
6.3.3 BRACELETS
6.3.4 MATTRESS DEVICES
6.3.5 ANTI-SUFFOCATION PILLOWS
6.3.6 OTHERS
6.4 IMPLANTABLE DEVICES
6.5 DIET
6.5.1 KETOGENIC DIET
6.5.2 OTHERS
7 GLOBAL EPILEPSY DEVICES MARKET, BY TECHNOLOGY
7.1 OVERVIEW
7.2 VAGUS NERVE STIMULATION
7.3 DEEP BRAIN STIMULATION
7.3.1 MOVEMENT DISORDERS
7.3.2 EPILEPSY
7.4 ACCELEROMETERY
7.5 RESPONSIVE NEUROSTIMULATION
8 GLOBAL EPILEPSY DEVICES MARKET, BY SEZIURE DETECTION AND PREDICTION DEVICES
8.1 OVERVIEW
8.2 ELECTROENCEPHALOGRAM
8.3 INTRACRANIAL EEG
8.4 SURFACE ELECTROMYOGRAPHY
8.5 ELECTROCARDIOGRAPHY
8.6 VIDEO DETECTION SYSTEMS
8.7 ELECTRODERMAL ACTIVITY
8.8 IMPLANTED ADVISORY SYSTEMS
8.9 OTHERS
9 GLOBAL EPILEPSY DEVICES MARKET BY END USER
9.1 OVERVIEW
9.2 HOSPITALS AND CLINICS
9.3 NEUROLOGY CENTERS
9.4 HOME CARE SETTINGS
9.5 OTHERS
10 GLOBAL EPILEPSY DEVICES MARKET, BY REGION
10.1 OVERVIEW
10.2 AMERICAS
10.2.1 NORTH AMERICA
10.2.1.1 US
10.2.1.2 CANADA
10.2.2 LATIN AMERICA
10.3 EUROPE
10.3.1 WESTERN EUROPE
10.3.1.1 GERMANY
10.3.1.2 FRANCE
10.3.1.3 UK
10.3.1.4 ITALY
10.3.1.5 SPAIN
10.3.1.6 REST OF WESTERN EUROPE
10.3.2 EASTERN EUROPE
10.4 ASIA PACIFIC
10.4.1 CHINA
10.4.2 INDIA
10.4.3 JAPAN
10.4.4 SOUTH KOREA
10.4.5 AUSTRALIA
10.4.6 REST OF ASIA PACIFIC
10.5 MIDDLE EAST & AFRICA
10.5.1 MIDDLE EAST
10.5.2 AFRICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 COMPETITIVE BENCHMARKING
11.3 MAJOR GROWTH STRATEGY IN THE GLOBAL EPILEPSY DEVICES MARKET
11.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL EPILEPSY DEVICES MARKET
11.5 KEY DEVELOPMENT ANALYSIS
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
11.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL
11.6.2 PARTNERSHIP/AGREEMENT
11.6.3 COLLABORATION
11.7 MAJOR PLAYERS FINANCIAL MATRIX
11.7.1 SALES (USD MILLION), 2020
11.7.2 R&D EXPENDITURE (USD MILLION), 2020
12 COMPANY PROFILES
12.1 LIVANOVA PLC
12.1.1 COMPANY OVERVIEW
12.1.2 FINANCIAL OVERVIEW
12.1.3 PRODUCTS/SERVICES OFFERED
12.1.4 KEY DEVELOPMENTS
12.1.5 SWOT ANALYSIS
12.1.6 KEY STRATEGIES
12.2 MEDTRONIC PLC
12.2.1 COMPANY OVERVIEW
12.2.2 FINANCIAL OVERVIEW
12.2.3 PRODUCTS/SERVICES OFFERED
12.2.4 KEY DEVELOPMENTS
12.2.5 SWOT ANALYSIS
12.2.6 KEY STRATEGIES
12.3 MEDPAGE LTD.
12.3.1 COMPANY OVERVIEW
12.3.2 FINANCIAL OVERVIEW
12.3.3 PRODUCTS/SERVICES OFFERED
12.3.4 KEY DEVELOPMENTS
12.3.5 SWOT ANALYSIS
12.3.6 KEY STRATEGIES
12.4 KONINKLIJKE PHILIPS NV
12.4.1 COMPANY OVERVIEW
12.4.2 FINANCIAL OVERVIEW
12.4.3 PRODUCTS/SERVICES OFFERED
12.4.4 KEY DEVELOPMENTS
12.4.5 SWOT ANALYSIS
12.4.6 KEY STRATEGIES
12.5 COMPUMEDICS LIMITED
12.5.1 COMPANY OVERVIEW
12.5.2 FINANCIAL OVERVIEW
12.5.3 PRODUCTS/SERVICES OFFERED
12.5.4 KEY DEVELOPMENTS
12.5.5 SWOT ANALYSIS
12.5.6 KEY STRATEGIES
12.6 NATUS MEDICAL INCORPORATED
12.6.1 COMPANY OVERVIEW
12.6.2 FINANCIAL OVERVIEW
12.6.3 PRODUCTS/SERVICES OFFERED
12.6.4 KEY DEVELOPMENTS
12.6.5 SWOT ANALYSIS
12.6.6 KEY STRATEGIES
12.7 NIHON KOHDEN CORPORATION
12.7.1 COMPANY OVERVIEW
12.7.2 FINANCIAL OVERVIEW
12.7.3 PRODUCTS/SERVICES OFFERED
12.7.4 KEY DEVELOPMENTS
12.7.5 SWOT ANALYSIS
12.7.6 KEY STRATEGIES
12.8 MC10
12.8.1 COMPANY OVERVIEW
12.8.2 FINANCIAL OVERVIEW
12.8.3 PRODUCTS/SERVICES OFFERED
12.8.4 KEY DEVELOPMENTS
12.8.5 SWOT ANALYSIS
12.8.6 KEY STRATEGIES
12.9 EMPATICA INC.
12.9.1 COMPANY OVERVIEW
12.9.2 FINANCIAL OVERVIEW
12.9.3 PRODUCTS/SERVICES OFFERED
12.9.4 KEY DEVELOPMENTS
12.9.5 SWOT ANALYSIS
12.9.6 KEY STRATEGIES
12.10 NEUROPACE, INC.
12.10.1 COMPANY OVERVIEW
12.10.2 FINANCIAL OVERVIEW
12.10.3 PRODUCTS/SERVICES OFFERED
12.10.4 KEY DEVELOPMENTS
12.10.5 SWOT ANALYSIS
12.10.6 KEY STRATEGIES
12.11 BOSTON SCIENTIFIC CORPORATION
12.11.1 COMPANY OVERVIEW
12.11.2 FINANCIAL OVERVIEW
12.11.3 PRODUCTS/SERVICES OFFERED
12.11.4 KEY DEVELOPMENTS
12.11.5 SWOT ANALYSIS
12.11.6 KEY STRATEGIES
13 APPENDIX
13.1 REFERENCES
13.2 RELATED REPORTS
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS
TABLE 2 GLOBAL: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 3 GLOBAL: EPILEPSY DEVICES MARKET, FOR CONVENTIONAL DEVICES, BY REGION, 2018–2027 (USD MILLION)
TABLE 4 GLOBAL: EPILEPSY DEVICES MARKET, FOR WEARABLE DEVICES, BY REGION, 2018–2027 (USD MILLION)
TABLE 5 GLOBAL: EPILEPSY DEVICES MARKET, FOR WATCHES, BY REGION, 2018–2027 (USD MILLION)
TABLE 6 GLOBAL: EPILEPSY DEVICES MARKET, FOR BRACELETS, BY REGION, 2018–2027 (USD MILLION)
TABLE 7 GLOBAL: EPILEPSY DEVICES MARKET, FOR BRACELETS, BY REGION, 2018–2027 (USD MILLION)
TABLE 8 GLOBAL: EPILEPSY DEVICES MARKET, FOR MATTRESS DEVICES, BY REGION, 2018–2027 (USD MILLION)
TABLE 9 GLOBAL: EPILEPSY DEVICES MARKET, FOR ANTI-SUFFOCATION PILLOWS, BY REGION, 2018–2027 (USD MILLION)
TABLE 10 GLOBAL: EPILEPSY DEVICES MARKET, FOR OTHERS, BY REGION, 2018–2027 (USD MILLION)
TABLE 11 GLOBAL: EPILEPSY DEVICES MARKET, FOR IMPLANTABLE DEVICES, BY REGION, 2018–2027 (USD MILLION)
TABLE 12 GLOBAL: EPILEPSY DEVICES MARKET, FOR DIET, BY REGION, 2018–2027 (USD MILLION)
TABLE 13 GLOBAL: EPILEPSY DEVICES MARKET, FOR KETOGENIC DIET, BY REGION, 2018–2027 (USD MILLION)
TABLE 14 GLOBAL: EPILEPSY DEVICES MARKET, FOR OTHERS, BY REGION, 2018–2027 (USD MILLION)
TABLE 15 GLOBAL: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)
TABLE 16 GLOBAL: EPILEPSY DEVICES MARKET, FOR VAGUS NERVE STIMULATION, BY REGION, 2018–2027 (USD MILLION)
TABLE 17 GLOBAL: EPILEPSY DEVICES MARKET, FOR DEEP BRAIN STIMULATION, BY REGION, 2018–2027 (USD MILLION)
TABLE 18 GLOBAL: EPILEPSY DEVICES MARKET, FOR MOVEMENT DISORDERS, BY REGION, 2018–2027 (USD MILLION)
TABLE 19 GLOBAL: EPILEPSY DEVICES MARKET, FOR EPILEPSY, BY REGION, 2018–2027 (USD MILLION)
TABLE 20 GLOBAL: EPILEPSY DEVICES MARKET, FOR ACCELEROMETERY, BY REGION, 2018–2027 (USD MILLION)
TABLE 21 GLOBAL: EPILEPSY DEVICES MARKET, FOR RESPONSIVE NEUROSTIMULATION, BY REGION, 2018–2027 (USD MILLION)
TABLE 22 GLOBAL: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2018–2027 (USD MILLION)
TABLE 23 GLOBAL: EPILEPSY DEVICES MARKET, FOR ELECTROENCEPHALOGRAM, BY REGION, 2018–2027 (USD MILLION)
TABLE 24 GLOBAL: EPILEPSY DEVICES MARKET, FOR INTRACRANIAL EEG, BY REGION, 2018–2027 (USD MILLION)
TABLE 25 GLOBAL: EPILEPSY DEVICES MARKET, FOR SURFACE ELECTROMYOGRAPHY, BY REGION, 2018–2027 (USD MILLION)
TABLE 26 GLOBAL: EPILEPSY DEVICES MARKET, FOR ELECTROCARDIOGRAPHY, BY REGION, 2018–2027 (USD MILLION)
TABLE 27 GLOBAL: EPILEPSY DEVICES MARKET, FOR VIDEO DETECTION SYSTEMS, BY REGION, 2018–2027 (USD MILLION)
TABLE 28 GLOBAL: EPILEPSY DEVICES MARKET, FOR ELECTRODERMAL ACTIVITY, BY REGION, 2018–2027 (USD MILLION)
TABLE 29 GLOBAL: EPILEPSY DEVICES MARKET, FOR IMPLANTED ADVISORY SYSTEMS, BY REGION, 2018–2027 (USD MILLION)
TABLE 30 GLOBAL: EPILEPSY DEVICES MARKET, FOR OTHERS, BY REGION, 2018–2027 (USD MILLION)
TABLE 31 GLOBAL: EPILEPSY DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 32 GLOBAL: EPILEPSY DEVICES MARKET, BY HOSPITALS & CLINICS, 2018–2027 (USD MILLION)
TABLE 33 GLOBAL: EPILEPSY DEVICES MARKET, BY NEUROLOGY CENTERS, 2018–2027 (USD MILLION)
TABLE 34 GLOBAL: EPILEPSY DEVICES MARKET, BY HOME CARE SETTINGS, 2018–2027 (USD MILLION)
TABLE 35 GLOBAL: EPILEPSY DEVICES MARKET, BY OTHERS, 2018–2027 (USD MILLION)
TABLE 36 GLOBAL: EPILEPSY DEVICES MARKET, BY REGION, 2018–2027 (USD MILLION)
TABLE 37 AMERICAS: EPILEPSY DEVICES MARKET, BY REGION, 2018–2027 (USD MILLION)
TABLE 38 AMERICAS: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 39 AMERICAS: EPILEPSY DEVICES MARKET FOR WEARABLE DEVICES, BY TYPE, 2018–2027 (USD MILLION)
TABLE 40 AMERICAS: EPILEPSY DEVICES MARKET FOR DIET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 41 AMERICAS: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)
TABLE 42 AMERICAS: EPILEPSY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE 2018–2027 (USD MILLION)
TABLE 43 AMERICAS: EPILEPSY DEVICES MARKET FOR SEZIURE DETECTION AND PREDICTION DEVICES, 2018–2027 (USD MILLION)
TABLE 44 AMERICAS: EPILEPSY DEVICES MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 45 NORTH AMERICA: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 46 NORTH AMERICA: EPILEPSY DEVICES MARKET FOR WEARABLE DEVICES, BY TYPE, 2018–2027 (USD MILLION)
TABLE 47 NORTH AMERICA: EPILEPSY DEVICES MARKET FOR DIET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 48 NORTH AMERICA: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)
TABLE 49 NORTH AMERICA: EPILEPSY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE 2018–2027 (USD MILLION)
